These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 554806)

  • 1. [Topical and microbiological evaluation of dideoxykanamycin B in comparison to other second and third generation aminoglycosides].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR; Mattina R
    G Ital Chemioter; 1979; 26(1-2):167-72. PubMed ID: 554806
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L; Van Thoi J; Le Soussy CJ; Duval J
    Nouv Presse Med; 1982 Nov; 11(46):3385-90. PubMed ID: 7155845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
    Weinstein RA; Nathan C; Gruensfelder R; Kabins SA
    J Infect Dis; 1980 Mar; 141(3):338-45. PubMed ID: 6767795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System].
    Peyret M; Albertini MT; Olleon M; Davenas C; Blanc V
    Pathol Biol (Paris); 1993 Apr; 41(4):329-36. PubMed ID: 8233631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of aminoside resistance in 430 strains of gram-negative bacilli in a hospital environment. Value of amikacine].
    Le Noc P; Croizé J
    Sem Hop Ther; 1977; 53(7-8):378-83. PubMed ID: 244369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amikacin in the treatment of Gram negative bacilli septicemias].
    Cartier F; Dien G; Cormier M; Hoel JC; Guivarch G
    Nouv Presse Med; 1979 Oct; 8(42):3510-12. PubMed ID: 537908
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of netilmicin against selected strains of Gram-negative bacteria and Staphylococcus aureus: comparison with four other aminoglycosides.
    Mouton RP; de Kok-Broeren MC
    J Antimicrob Chemother; 1977 Sep; 3(5):393-401. PubMed ID: 903322
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to aminoglycosides among gram - negative bacteria].
    Akalin E; Baykal M
    Mikrobiyol Bul; 1982 Jan; 16(1):1-4. PubMed ID: 7144617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
    Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological considerations in the use of tobramycin and related aminoglycosidic aminocyclitol antibiotics.
    Moellering RC
    Med J Aust; 1977 Oct; 2(3 Pt 1 Suppl):4-8. PubMed ID: 600197
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro sensitivity of gram-negative. Aerobic bacteria to tobramycin and gentamicin.
    Tortorici MP
    Am J Hosp Pharm; 1977 Feb; 34(2):119-24. PubMed ID: 842537
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.